Chinese General Practice ›› 2022, Vol. 25 ›› Issue (29): 3646-3651.DOI: 10.12114/j.issn.1007-9572.2022.0442
• Article • Previous Articles Next Articles
Received:
2022-04-08
Revised:
2022-07-07
Published:
2022-10-15
Online:
2022-07-21
Contact:
Defeng PAN
About author:
通讯作者:
潘德锋
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0442
项目 | 左心室舒张功能不全组(n=47) | 左心室舒张功能正常组(n=50) | 检验统计量值 | P值 |
---|---|---|---|---|
性别(男/女) | 22/25 | 36/14 | 6.395a | 0.011 |
年龄( | 66.6±8.2 | 59.4±10.4 | 3.775 | <0.001 |
BMI( | 25.6±3.6 | 25.2±3.6 | 0.507 | 0.614 |
糖尿病病史〔n(%)〕 | 32(68.1) | 15(30.0) | 14.07a | <0.001 |
高血压病史〔n(%)〕 | 29(61.7) | 19(38.0) | 5.445a | 0.020 |
吸烟〔n(%)〕 | 11(23.4) | 15(30.0) | 0.537a | 0.464 |
饮酒〔n(%)〕 | 9(19.1) | 8(16.0) | 0.166a | 0.684 |
SBP( | 137±17 | 134±17 | 1.029 | 0.306 |
DBP( | 77±10 | 80±9 | -1.588 | 0.116 |
HR( | 68.55±8.42 | 69.78±9.19 | -0.684 | 0.496 |
GFR( | 103.01±13.33 | 97.88±18.94 | 1.067 | 0.291 |
空腹血糖( | 5.85±1.41 | 6.24±1.79 | -1.111 | 0.270 |
血红蛋白( | 130.00±14.43 | 134.88±15.15 | -1.613 | 0.110 |
白细胞计数( | 6.10±1.89 | 6.38±1.69 | -0.773 | 0.442 |
TC( | 3.86±1.09 | 3.79±0.92 | 0.346 | 0.730 |
TG〔M(P25,P75),mmol/L〕 | 1.49(0.99,2.45) | 1.26(0.87,2.35) | -0.586b | 0.558 |
HDL-C( | 0.97±0.24 | 0.97±0.29 | 0.102 | 0.919 |
LDL-C( | 2.14±0.82 | 2.23±0.78 | -0.562 | 0.576 |
脂蛋白a〔M(P25,P75),mg/L〕 | 237(180,343) | 282(154,375) | -0.477b | 0.634 |
C反应蛋白〔M(P25,P75),mg/L〕 | 1.40(0.70,4.55) | 1.40(0.50,4.50) | -0.586b | 0.558 |
NT-ProBNP〔M(P25,P75),ng/L〕 | 103.00(74.35,402.00) | 87.20(48.60,173.00) | -1.946b | 0.052 |
hsTnT〔M(P25,P75),ng/L〕 | 8.84(6.81,16.54) | 7.80(6.13,15.00) | -0.092b | 0.927 |
Table 1 Comparison of general data between coronary artery disease with left ventricular diastolic function and left ventricular diastolic dysfunction
项目 | 左心室舒张功能不全组(n=47) | 左心室舒张功能正常组(n=50) | 检验统计量值 | P值 |
---|---|---|---|---|
性别(男/女) | 22/25 | 36/14 | 6.395a | 0.011 |
年龄( | 66.6±8.2 | 59.4±10.4 | 3.775 | <0.001 |
BMI( | 25.6±3.6 | 25.2±3.6 | 0.507 | 0.614 |
糖尿病病史〔n(%)〕 | 32(68.1) | 15(30.0) | 14.07a | <0.001 |
高血压病史〔n(%)〕 | 29(61.7) | 19(38.0) | 5.445a | 0.020 |
吸烟〔n(%)〕 | 11(23.4) | 15(30.0) | 0.537a | 0.464 |
饮酒〔n(%)〕 | 9(19.1) | 8(16.0) | 0.166a | 0.684 |
SBP( | 137±17 | 134±17 | 1.029 | 0.306 |
DBP( | 77±10 | 80±9 | -1.588 | 0.116 |
HR( | 68.55±8.42 | 69.78±9.19 | -0.684 | 0.496 |
GFR( | 103.01±13.33 | 97.88±18.94 | 1.067 | 0.291 |
空腹血糖( | 5.85±1.41 | 6.24±1.79 | -1.111 | 0.270 |
血红蛋白( | 130.00±14.43 | 134.88±15.15 | -1.613 | 0.110 |
白细胞计数( | 6.10±1.89 | 6.38±1.69 | -0.773 | 0.442 |
TC( | 3.86±1.09 | 3.79±0.92 | 0.346 | 0.730 |
TG〔M(P25,P75),mmol/L〕 | 1.49(0.99,2.45) | 1.26(0.87,2.35) | -0.586b | 0.558 |
HDL-C( | 0.97±0.24 | 0.97±0.29 | 0.102 | 0.919 |
LDL-C( | 2.14±0.82 | 2.23±0.78 | -0.562 | 0.576 |
脂蛋白a〔M(P25,P75),mg/L〕 | 237(180,343) | 282(154,375) | -0.477b | 0.634 |
C反应蛋白〔M(P25,P75),mg/L〕 | 1.40(0.70,4.55) | 1.40(0.50,4.50) | -0.586b | 0.558 |
NT-ProBNP〔M(P25,P75),ng/L〕 | 103.00(74.35,402.00) | 87.20(48.60,173.00) | -1.946b | 0.052 |
hsTnT〔M(P25,P75),ng/L〕 | 8.84(6.81,16.54) | 7.80(6.13,15.00) | -0.092b | 0.927 |
指标 | 左心室舒张功能不全组(n=47) | 左心室舒张功能正常组(n=50) | Z(t)值 | P值 | |
---|---|---|---|---|---|
SPECT参数 | |||||
LVESV'〔M(P25,P75),ml〕 | 41(32,54) | 38(34,51) | -0.419 | 0.675 | |
LVEDV'〔M(P25,P75),ml〕 | 101(84,117) | 101(87,125) | -0.567 | 0.571 | |
LVEF'( | 56.96±7.46 | 60.36±8.37 | -2.111a | 0.037 | |
PFR〔M(P25,P75),EDC/s〕 | 2.02(1.73,2.48) | 2.68(2.22,3.25) | -4.714 | <0.001 | |
1/3FF〔M(P25,P75),%〕 | 33.0 (25.0,38.0) | 39.0 (30.5,45.3) | -2.748 | 0.006 | |
1/3FR( | 1.75±0.61 | 2.03±0.52 | -2.456a | 0.016 | |
MFR〔M(P25,P75),EDC/s〕 | 1.25(1.03,1.38) | 1.36(1.23,1.54) | -2.769 | 0.006 | |
TPF( | 179.96±34.99 | 148.22±29.48 | 4.842a | <0.001 | |
心导管检查 | |||||
LVESV〔M(P25,P75),ml〕 | 36(29,52) | 36(29,47) | -0.148 | 0.882 | |
LVEDV〔M(P25,P75),ml〕 | 100(87,136) | 104(85,155) | -0.834 | 0.404 | |
LVEF( | 63.51±7.80 | 65.74±10.14 | -1.211a | 0.229 |
Table 2 Comparison of cardiac function parameters obtained by SPECT and cardiac catheterization between the two groups
指标 | 左心室舒张功能不全组(n=47) | 左心室舒张功能正常组(n=50) | Z(t)值 | P值 | |
---|---|---|---|---|---|
SPECT参数 | |||||
LVESV'〔M(P25,P75),ml〕 | 41(32,54) | 38(34,51) | -0.419 | 0.675 | |
LVEDV'〔M(P25,P75),ml〕 | 101(84,117) | 101(87,125) | -0.567 | 0.571 | |
LVEF'( | 56.96±7.46 | 60.36±8.37 | -2.111a | 0.037 | |
PFR〔M(P25,P75),EDC/s〕 | 2.02(1.73,2.48) | 2.68(2.22,3.25) | -4.714 | <0.001 | |
1/3FF〔M(P25,P75),%〕 | 33.0 (25.0,38.0) | 39.0 (30.5,45.3) | -2.748 | 0.006 | |
1/3FR( | 1.75±0.61 | 2.03±0.52 | -2.456a | 0.016 | |
MFR〔M(P25,P75),EDC/s〕 | 1.25(1.03,1.38) | 1.36(1.23,1.54) | -2.769 | 0.006 | |
TPF( | 179.96±34.99 | 148.22±29.48 | 4.842a | <0.001 | |
心导管检查 | |||||
LVESV〔M(P25,P75),ml〕 | 36(29,52) | 36(29,47) | -0.148 | 0.882 | |
LVEDV〔M(P25,P75),ml〕 | 100(87,136) | 104(85,155) | -0.834 | 0.404 | |
LVEF( | 63.51±7.80 | 65.74±10.14 | -1.211a | 0.229 |
参数 | 截断值 | 灵敏度(%) | 特异度(%) | 约登指数 | AUC | 95%CI | P值 |
---|---|---|---|---|---|---|---|
PFR | 2.12 EDC/s | 60 | 84 | 0.436 | 0.778 | (0.687,0.869) | <0.001 |
1/3FF | 37.5% | 75 | 62 | 0.365 | 0.662 | (0.551,0.772) | 0.006 |
1/3FR | 1.75 EDC/s | 57 | 78 | 0.354 | 0.653 | (0.542,0.764) | 0.009 |
MFR | 1.28 EDC/s | 62 | 68 | 0.297 | 0.663 | (0.554,0.772) | 0.006 |
TPF | 185.50 ms | 77 | 70 | 0.466 | 0.755 | (0.658,0.852) | <0.001 |
Table 3 ROC curve analysis of SPECT parameters predicting elevated LVEDP
参数 | 截断值 | 灵敏度(%) | 特异度(%) | 约登指数 | AUC | 95%CI | P值 |
---|---|---|---|---|---|---|---|
PFR | 2.12 EDC/s | 60 | 84 | 0.436 | 0.778 | (0.687,0.869) | <0.001 |
1/3FF | 37.5% | 75 | 62 | 0.365 | 0.662 | (0.551,0.772) | 0.006 |
1/3FR | 1.75 EDC/s | 57 | 78 | 0.354 | 0.653 | (0.542,0.764) | 0.009 |
MFR | 1.28 EDC/s | 62 | 68 | 0.297 | 0.663 | (0.554,0.772) | 0.006 |
TPF | 185.50 ms | 77 | 70 | 0.466 | 0.755 | (0.658,0.852) | <0.001 |
[1] |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志,2021,36(6):521-545. DOI:10.3969/j.issn.1000-3614.2021.06.001.
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等.稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志,2018,46(9):680-694. DOI:10.3760/cma.j.issn.0253-3758.2018.09.004.
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
马红,吴伟春,谢荣爱,等. 三维斑点追踪超声心动图评估冠心病患者左心室舒张功能的临床应用价值[J]. 中国循环杂志,2015,30(3):225-229. DOI:10.3969/j.issn.1000-3614.2015.03.007.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
赵慧兰. G-SPECT测定左室容积和射血分数:与左室造影和超声心动图比较[D]. 太原:山西医科大学,2006.
|
[20] |
|
[21] |
|
[22] |
|
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||